Trial Parameters
Brief Summary
The goal of this clinical trial is to explore the brain's electrical reactivity, monitored using EEG, following the EXOMIND (BTL-699-2) stimulation across various stimulation locations. The main question it aims to answer is: What is the brain's cortical electrical reactivity, monitored using EEG, following the EXOMIND (BTL-699-2) stimulation across various stimulation locations? Participants will be asked to: * Undergo 1 treatment visit * Undergo electroencephalography (EEG) measurements * Complete Therapy Comfort Questionnaires
Eligibility Criteria
Inclusion Criteria: * Age \> 19 years * Ability to determine the motor threshold of the participant. * Willingness to maintain on pre-study psychotherapeutic regime, and prescribed medications at a stable therapeutic dosage for at least 2 months prior to study entry. * Willingness to comply with study instructions and to return to the clinic for the required visits * Willingness to undergo EEG examination and proceed with the instructions from the study staff during the measurement * Women of child-bearing potential are required to use birth control measures during the whole duration of the study Exclusion Criteria: * electronic implants (Implanted stimulator devices in or near the head - rTMS devices are contraindicated for use in patients who have active or inactive implants including device leads, deep brain stimulators, cochlear implants, ocular implants, and vagus nerve stimulators, implanted devices such as cardiac pacemakers, defibrillators, and neurostimulators.), * metallic, f